Comparison of Safety and Clinical Benefit of Injections Subcutaneously Talazoparib Versus Oral Talazoparib in Patients With Solid Tumors
Clinical trial NCT03426254 · WITHDRAWN
Trial details
- NCT number
- NCT03426254
- Sponsor
- Center Trials & Treatment
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-10
- Primary completion
- 2023-12-10
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.